Dorothy Clarke

Insider Reports History

Entity
Individual
Location
C/O Eterna Therapeutics Inc., 1035 Cambridge Street, Ste. 18 A, Cambridge, MA
Signature
/s/ Dorothy Clarke
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dorothy Clarke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eterna Therapeutics Inc. General Counsel, Director Stock Option (right to buy) 169K Jan 1, 2024 Direct
Comera Life Sciences Holdings, Inc. Director Stock Option (Right to Purchase 14.2K Nov 7, 2023 Direct

Insider Reports Filed by Dorothy Clarke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ERNA Eterna Therapeutics Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 General Counsel, Director
CMRA Comera Life Sciences Holdings, Inc. Nov 7, 2023 1 $0 4 Nov 13, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Nov 7, 2023 0 $0 3 Nov 13, 2023 Director
ERNA Eterna Therapeutics Inc. Aug 28, 2023 0 $0 3 Sep 1, 2023 Director